<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Reprod Biomed (Yazd)</journal-id><journal-id journal-id-type="iso-abbrev">Int J Reprod Biomed (Yazd)</journal-id><journal-id journal-id-type="publisher-id">IJRB</journal-id><journal-title-group><journal-title>International Journal of Reproductive Biomedicine</journal-title></journal-title-group><issn pub-type="ppub">2476-4108</issn><issn pub-type="epub">2476-3772</issn><publisher><publisher-name>Research and Clinical Center for Infertility</publisher-name><publisher-loc>Yazd, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28744522</article-id><article-id pub-id-type="pmc">5510580</article-id><article-id pub-id-type="publisher-id">ijrb-16-273</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The effects of multi mineral-vitamin D and vitamins (C+E) supplementation in the prevention of preeclampsia: An RCT</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Azami</surname><given-names>Milad</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Azadi</surname><given-names>Tayebe</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Farhang</surname><given-names>Sepidezahra</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Rahmati</surname><given-names>Shoobo</given-names></name><degrees>M.Sc.</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pourtaghi</surname><given-names>Khadijeh</given-names></name><degrees>M.D.</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<italic>Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran.</italic>
</aff><aff id="aff2">
<label>2</label>
<italic>Nursing and Midwifery Faculty, Ilam University of Medical Sciences, Ilam, Iran.</italic>
</aff><aff id="aff3">
<label>3</label>
<italic>Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.</italic>
</aff><author-notes><corresp id="cor">Corresponding Author: Khadijeh Pourtaghi, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran. Email: kh.pourtaghi@yahoo.com, Tel: (+98) 9187217728</corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2017</year></pub-date><volume>15</volume><issue>5</issue><fpage>273</fpage><lpage>278</lpage><history><date date-type="received"><day>14</day><month>6</month><year>2016</year></date><date date-type="rev-recd"><day>1</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2017</year></date></history><permissions><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Several studies have reported the uncertain role of multi-minerals and vitamins in the prevention of preeclampsia. </p></sec><sec><title>Objective:</title><p>The present study aims to investigate the effect of multimineral-vitamin D supplements (calcium, magnesium, zinc and Vitamin D) and vitamins (C+ E) in the prevention of preeclampsia.</p></sec><sec><title>Materials and Methods:</title><p>In this randomized clinical trial, 90 pregnant women were divided into three groups: group A received Ferrous sulfate (1 tablet/day) + one tablet of Claci-care multimineral-vitamin D containing 800mg calcium, 200mg magnesium, 8mg zinc and 400 IU Vitamin D3 per day; group B received Ferrous sulfate (1 tablet/day) + 250 mg vitamin C + 55 mg vitamin E; and the controls received only one Ferrous sulfate tablet daily. </p></sec><sec><title>Results:</title><p>The incidence of preeclampsia in group A was significantly lower than the control group (p=0.03), while there was no significant difference between group B and controls (p=0.50), as well as groups A and B (p=0.063). The incidence of neonatal complications in the group A was significantly lower than the control group (p=0.01), while there was no significant difference between group B and control (p=0.48).</p></sec><sec><title>Conclusion:</title><p>According to the results, calcium, magnesium, and zinc supplements have a significant effect on the prevention of preeclampsia. In addition, prescription of multimineral-vitamin D during pregnancy can be a low-cost and affordable way to reduce the incidence of preeclampsia in women who are at high risk of preeclampsia. </p></sec></abstract><kwd-group><title>Key Words</title><kwd>Prevention</kwd><kwd>Preeclampsia</kwd><kwd>Calcium</kwd><kwd>Magnesium</kwd><kwd>Zinc</kwd><kwd>Vitamin D</kwd><kwd>Vitamin C</kwd><kwd>Vitamin E</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Preeclampsia (PE) is a leading cause of maternal and prenatal mortality, particularly in poor and developing countries (<xref rid="B1" ref-type="bibr">1</xref>). The prevalence of PE has been reported to be 5-7% of all pregnancies (<xref rid="B2" ref-type="bibr">2</xref>-<xref rid="B4" ref-type="bibr">4</xref>). PE is described by certain symptoms including: high blood pressure (&#x02265;140/90) after week 20 of pregnancy, and proteinuria &#x02265;300 mg per 24 Hr. equal to +1 in urine dipstick (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>). PE affects mothers and fetuses&#x02019; health during pregnancy, therefore, PE prevention is highly crucial (<xref rid="B1" ref-type="bibr">1</xref>). The most serious complications of PE in mothers and fetuses&#x02019; health include increasing maternal mortality, thrombophilic disorders, edema, eclampsia, liver or kidney failure, stroke, cardiovascular diseases, intrauterine growth retardation, prematurity, and embryonic death (<xref rid="B6" ref-type="bibr">6</xref>-<xref rid="B10" ref-type="bibr">10</xref>).</p><p>Some studies indicate poor nutrition (especially protein, calcium (Ca), sodium, magnesium (Mg), and vitamins )A, C, E) as factors that exacerbate PE. Furthermore, in some researches diets including calcium supplements have been rejected regarding prevention of PE (<xref rid="B11" ref-type="bibr">11</xref>-<xref rid="B13" ref-type="bibr">13</xref>). Kanagal <italic>et al</italic> and Jain <italic>et al</italic> concluded that serum levels of multimineral-vitamin D (Zinc (Zn), Mg, Ca and vitamin D3) during pregnancy can affect the preeclampsia. However, this was not significant in the study of Vafaei <italic>et al</italic> (<xref rid="B14" ref-type="bibr">14</xref>-<xref rid="B16" ref-type="bibr">16</xref>). </p><p>Considering the importance of PE in maternal and fetal health as well as controversial results of studies on the role of multimineral-vitamin D and vitamins in the prevention of PE, the present study aims to investigate the effect of multimineral-vitamin D supplementation (Zn, Mg, Ca and vitamin D3) and vitamins (C+E) in the prevention of PE.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><p>
<bold>Study design</bold>
</p><p>In this randomized controlled clinical trial, 90 pregnant women who referred to Ilam Educational Center of Obstetrics and Gynecology, Iran in 2014, were divided into three groups (n=30). The sample size was determined based on 95% confidence interval, an alpha error of 5%, the power of 90%, and the prevalence of 5-7% PE (<xref rid="B2" ref-type="bibr">2</xref>-<xref rid="B4" ref-type="bibr">4</xref>). </p><p>Our inclusion criteria included women with least one of the risk factors for PE [including chronic vascular disease, hydatidiform mole, multiparity, diabetes mellitus, thyroid disease, chronic hypertension, nulliparity, history of preeclampsia, maternal age &#x0003e;35 years, kidney disease, collagen vascular disease, antiphospholipid antibody syndrome, family history of preeclampsia, history of thrombophilia, and obesity (BMI &#x0003e;25)] older than 20 weeks of gestational age who have received ferrous sulfate according to prenatal care program. Women who had several changes in diet during the trial were excluded from the study.</p><p>After obtaining informed consent and explaining the purpose of the study, participants were randomly divided into 3 groups according to randomized selection: Group A received one Ferrous sulfate tablet (Rooz daru&#x000a9;, Iran) + one Claci-care multimineral-vitamin D tablet [(Vitane Pharma&#x000a9;, Germany) contained 800 mg Ca, 200mg Mg, 8mg Zn and 400 IU vitamin D3)] per day; Group B received one Ferrous sulfate tablet (Rooz daru&#x000a9;, Iran,) + 250 mg vitamin C and 55 mg vitamin E, and control group only received Ferrous sulfate daily.</p><p>The patients with gestational age of 20-28, 28-36, and &#x0003e;36 wk were visited monthly, once every 2 wk, and weekly, respectively, for evaluation of blood pressure and proteinuria in our Obstetrics and Gynecology Clinic. Diagnosis of PE was done by a gynecologist using the high blood pressure &#x02265;140/90 after week 20 of pregnancy and proteinuria &#x02265;300 mg per 24 Hrs. or equal to +1 in urine dipstick (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B5" ref-type="bibr">5</xref>).</p><p>
<bold>Ethical consideration</bold>
</p><p>This study was approved by the Ethics Committee of the Medical University of Ilam, Iran (EC/93/H223).</p><p>
<bold>Statistical analysis</bold>
</p><p>Data were analyzed using Statistical Package for the Social Sciences, version 17.0, SPSS Inc, Chicago, Illinois, USA (SPSS) as well as Student&#x02019;s <italic>t</italic>-test, Chi-square, Fisher, and ANOVA test.</p></sec><sec sec-type="results"><title>Results</title><p>100 pregnant women were randomly divided into three groups: Group A (n=33), group B (n=36) and control group (n=34). In the control group, four women (lack of ferrous sulphate use [n=2] and many changes in diet during the trial [n=2]) were excluded. The exclusions in the group A included three women (lack of cooperation [n=1] and many changes in diet during the trial [n=2]). The exclusions in the group B included three women (lack of ferrous sulfate use [n=2] and many changes in diet during the trial [n=1]). Finally, 90 women (Group A [n=30], group B [n=30] and control group [n=30]) completed the trial (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><p>Overall, 90 pregnant women in three groups were included in this study. The mean age of study participants was 31.63&#x000b1;6.13 yr. The mean age of participants was not statistically different between groups A, B, and controls (33.03&#x000b1;6.49, 31.73&#x000b1;6.41, and 30.63&#x000b1;5.28 yr, respectively, P=0.18) Demographic characteristics are shown in <xref ref-type="table" rid="T1">table I</xref>. The incidence of preeclampsia in the group A was significantly lower than the controls (13.3% vs. 36.7%, p=0.03) but the incidence of preeclampsia in the group B was not different from the control group (33.3% vs. 36.7%, p=0.50) and also groups A and B (p=0.063) (<xref ref-type="fig" rid="F2">Figure 2</xref>). <xref ref-type="fig" rid="F3">Figure 3</xref> shows the risk of neonatal complications in the A, and control groups. Group A had a signi&#x0fb01;cantly reduced risk of neonatal complications (p=0.01), but this association in the group B was not statistically significant (p=0.48).</p><table-wrap id="T1" position="float"><label>Table I</label><caption><p>Demographic characteristics of participants in three groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" colspan="3" rowspan="1">
<bold>Variables</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Group A (n=30)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Group B (n=30)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Control (n=30)</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>Total</bold>
</th><th align="center" valign="middle" rowspan="1" colspan="1">
<bold>p-value</bold>
</th></tr></thead><tbody><tr><td align="left" valign="middle" colspan="3" rowspan="1">Age (yr)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">33.03&#x000b1;6.49</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">31.73&#x000b1;6.41</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">30.13&#x000b1;5.28</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">31.63&#x000b1;6.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.188</td></tr><tr><td align="left" valign="middle" colspan="3" rowspan="1">Gestational age (at the delivery time) (wk)<xref ref-type="table-fn" rid="TFN1">*</xref></td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">37.53&#x000b1;1.47</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">38.00&#x000b1;2.49</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">37.56&#x000b1;1.52</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">37.7&#x000b1;1.88</td><td align="center" valign="middle" rowspan="1" colspan="1">0.568</td></tr><tr><td align="left" valign="middle" colspan="7" rowspan="1">Level of education n(%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="3" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Under diploma</td><td align="center" valign="middle" colspan="2" rowspan="1">2 (8.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (34.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="3" colspan="1">0.004</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Diploma</td><td align="center" valign="middle" colspan="2" rowspan="1">20 (37)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (37)</td><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Undergraduate</td><td align="center" valign="middle" colspan="2" rowspan="1">8 (61.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (15.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td></tr><tr><td align="left" valign="middle" colspan="7" rowspan="1">Job n(%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="2" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Housekeeper</td><td align="center" valign="middle" colspan="2" rowspan="1">21 (27.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">26 (33.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (39)</td><td align="center" valign="middle" rowspan="1" colspan="1">77</td><td align="center" valign="middle" rowspan="2" colspan="1">0.004</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Employee</td><td align="center" valign="middle" colspan="2" rowspan="1">9 (69.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (30.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td></tr><tr><td align="left" valign="middle" colspan="7" rowspan="1">Family monthly income n(%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="6" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003c;0.5 million toman</td><td align="center" valign="middle" colspan="2" rowspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="6" colspan="1">0.002</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">0.5-1 million toman</td><td align="center" valign="middle" colspan="2" rowspan="1">7 (21.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (27.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">17 (51.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">33</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1-2 million toman</td><td align="center" valign="middle" colspan="2" rowspan="1">17 (38.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (40.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (20.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">44</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2-2.5 million toman</td><td align="center" valign="middle" colspan="2" rowspan="1">1 (50)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (50)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2.5-3 million toman</td><td align="center" valign="middle" colspan="2" rowspan="1">4 (100)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x0003e;3 million toman</td><td align="center" valign="middle" colspan="2" rowspan="1">1 (33.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (66.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="middle" colspan="8" rowspan="1">Residence n (%)</td></tr><tr><td align="left" valign="middle" rowspan="2" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1">Urban</td><td align="center" valign="middle" colspan="2" rowspan="1">30 (46.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (34.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (18.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td><td align="center" valign="middle" rowspan="2" colspan="1">0.000</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Rural</td><td align="center" valign="middle" colspan="2" rowspan="1">0 (0)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (69.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (30.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">26</td></tr><tr><td align="left" valign="middle" colspan="8" rowspan="1">Type of delivery n(%)</td></tr><tr><td align="left" valign="middle" rowspan="2" colspan="1"/><td style=" color:#auto;" align="left" valign="middle" rowspan="1" colspan="1">Normal vaginal delivery</td><td style=" color:#auto;" align="center" valign="middle" colspan="2" rowspan="1">7 (20.6)</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">10 929.4)</td><td style=" color:#auto;" align="center" valign="middle" rowspan="1" colspan="1">17 (50)</td><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="2" colspan="1">0.024</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cesarean section</td><td align="center" valign="middle" colspan="2" rowspan="1">23 (41.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (35.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">13 (23.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">56</td></tr></tbody></table><table-wrap-foot><p>Chi-Square Tests for qualitative variables and ANOVA Test for quantitative variable</p><fn id="TFN1"><label>*</label><p> Data presented as mean&#x000b1;SD. </p></fn></table-wrap-foot></table-wrap><fig id="F1" position="float"><label>Figure 1</label><caption><p>Follow-up Method Based on CONSORT 2010 Flow Diagram</p></caption><graphic xlink:href="ijrb-15-273-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Comparison of the effect of multimineral-vitamin D (Zn, Mg, Ca and vitamin D3) and vitamins (C and E) supplementations in the prevention of preeclampsia</p></caption><graphic xlink:href="ijrb-15-273-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>Comparison of the effect of multimineral-vitamin D (Zn, Mg, Ca and vitamin D3) and vitamins (C and E) supplementations in the neonatal complications</p></caption><graphic xlink:href="ijrb-15-273-g003"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>This study showed that consumption of multimineral-vitamin D (Zn, Mg, Ca and vitamin D3) among pregnant women at risk of preeclampsia reduced the incidence of preeclampsia. In this regard, Jain and Kim in their study concluded that administration of multi-minerals (Ca, Mg, and Zn) during pregnancy can be effective in the prevention of preeclampsia (<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Abedi <italic>et al</italic> in a study demonstrated that vitamin D levels in preeclampsia group was less than healthy subjects, suggesting that vitamin D is effective in prevention of preeclampsia (<xref rid="B18" ref-type="bibr">18</xref>). In addition, Kanagal <italic>et al</italic> found that serum Ca concentration was significantly lower in the preeclampsia group compared with healthy pregnant women (<xref rid="B14" ref-type="bibr">14</xref>). The results of these studies were consistent with our results. But Vafaei <italic>et al</italic> reported that the serum levels of Ca, Mg, and Zn in normotensive women were not significantly different from preeclamptic women (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>Comparing the case group (E and C) with control group showed a percentage of 33.3% and 36.6% preeclampsia in pregnant women and this difference was not statistically significant (p=0.50). In this regard, Spinnato <italic>et al</italic> in a clinical trial showed that the incidence of preeclampsia was 13.8% in pregnant women who received vitamins E+C and 15.6% in women who received placebo, and this difference was not statistically significant (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>Moreover, based on two systematic reviews by Polyzos and Salles <italic>et al</italic> showed that taking vitamins E and C does not reduce the risk of preeclampsia during pregnancy (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). However, studies of Chappell <italic>et al</italic> and Zhang <italic>et al</italic> among women at risk of preeclampsia demonstrated that co-administration of vitamins E and C effected the prevention of pre-eclampsia (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). According to another study, Bowen <italic>et al</italic> indicated that vitamin C reduced the risk of preeclampsia (<xref rid="B24" ref-type="bibr">24</xref>). Therefore, the results of these studies are not in line with the present study, which might be due to different sample size, different populations studied in various geographical areas, diversity in nutrition and diet and different races.</p><p>In this study, there was a significant reduction in the incidence of neonatal complications in the multimineral-vitamin D supplementation group, but this association in the vitamins supplementation group was not statistically significant. So, it seems that multimineral-vitamin D supplementation in pregnant women at the risk of preeclampsia decreased the risk of neonatal complications by reducing the incidence of preeclampsia. </p><p>Furthermore, in the present study, no significant relationship was found between the mother&#x02019;s obesity and incidence of preeclampsia (p=0.56) which was consistent with the experiment of Dabirieskoei <italic>et al</italic> (<xref rid="B25" ref-type="bibr">25</xref>). Furthermore, a systematic review and meta-analysis of 13 cohort studies showed that with increasing 5-7 kg/m<sup>2</sup> of the mother&#x02019;s weight, the risk of preeclampsia doubles, which, due to low sample size of our study, our results were not consistent with this meta-analysis (<xref rid="B26" ref-type="bibr">26</xref>). </p><p>In this study, there was a significant reduction in the incidence of neonatal complications in the multimineral-vitamin D supplementation group. Furthermore, in a clinical trial by Asemi <italic>et al</italic> which analyzed the effect of multi-mineral and vitamin D supplement on pregnancy outcomes in pregnant women at risk for pre-eclampsia, showed that consumption of multi-minerals (Zn, Mg, and Ca) leads to an increase height, calcium, magnesium, zinc levels in newborns compared with the placebo group (<xref rid="B27" ref-type="bibr">27</xref>). Robinson and Ghomian studied the relationship between vitamin D deficiency, preeclampsia and fetal growth retardation and indicated that Vitamin D supplementation may improve the outcome of pregnancy to prevent or delay pre-eclampsia and fetal growth problems in the high-risk group (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>).</p><p>Overall, it seems that multimineral-vitamin D supplementation in pregnant women at the risk of preeclampsia decreased the risk of neonatal complications by reducing the incidence of preeclampsia. Moreover, the present study showed that association between vitamins E+C supplementation group and incidence of neonatal complications was not statistically significant.</p><p>In this regard, Polyzos <italic>et al</italic> in their systematic review demonstrated that consumption of vitamin C and vitamin E supplements during pregnancy cannot decrease the risk of fetal or neonatal death, preterm delivery and small size for gestational age (<xref rid="B20" ref-type="bibr">20</xref>). Rumbold in a review study regarding the effect of co-administration of vitamins E+C during pregnancy did not report a significant relationship with reduction of pre-eclampsia and other serious adverse effects of pregnancy (<xref rid="B30" ref-type="bibr">30</xref>). Moreover, Rumbold achieved similar results in another study (<xref rid="B31" ref-type="bibr">31</xref>). Rahmaniyan showed that consumption of vitamin C and vitamin E supplements reduces risk of low birth weight, but does not effect stillbirth and small size for gestational age (<xref rid="B32" ref-type="bibr">32</xref>).</p><p>
<bold>Limitation</bold>
</p><p>Limitations of the present study include not dividing preeclampsia into different severities. Therefore, we couldn&#x02019;t investigate the relationship between supplementations and the severity of preeclampsia or gestational age. Moreover, considering failure to check nutritional information and diet in the patients because of lack of cooperation, it is recommended to be considered in future studies. </p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>According to the results of this study, considering the significant effect of multi-minerals supplements (Ca, Mg, and Zn) in the prevention of preeclampsia and taking these multi-minerals during pregnancy can be a low-cost and affordable way to reduce the incidence of preeclampsia in women who are at high risk of preeclampsia. On the other hand, it was found that taking multi-minerals reduce the incidence of neonatal complications. Vitamins C and E supplementation had no effect on the prevention and complications of preeclampsia.</p></sec></body><back><ack><title>Acknowledgments</title><p>We are grateful to the Ilam University of Medical sciences for financial support.</p></ack><sec sec-type="COI-statement"><title>Conflict of interest</title><p>Authors have no conflict of interest.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steegers</surname><given-names>EA</given-names></name><name><surname>von</surname><given-names>Dadelszen P</given-names></name><name><surname>Duvekot</surname><given-names>JJ</given-names></name><name><surname>Pijnenborg</surname><given-names>R</given-names></name></person-group><article-title>Pre-eclampsia</article-title><source> Lancet</source><year>2010</year><volume>376</volume><fpage>631</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">20598363</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksoy</surname><given-names>&#x000dc;</given-names></name><name><surname>Aksoy</surname><given-names>H</given-names></name><name><surname>A&#x000e7;maz</surname><given-names>G</given-names></name><name><surname>Babayi&#x0011f;it</surname><given-names>M</given-names></name><name><surname>Kandemir</surname><given-names>&#x000d6;</given-names></name></person-group><article-title>Umbilical artery serum chitotriosidase concentration in pregnancies complicated by preeclampsia and relationship between chitotriosidase levels and fetal blood flow velocity</article-title><source> Hypertens Pregnancy</source><year>2013</year><volume>32</volume><fpage>401</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">23844836</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tayyar</surname><given-names>A</given-names></name><name><surname>Tayyar</surname><given-names>AT</given-names></name><name><surname>Abd&#x000fc;lrezzak</surname><given-names>&#x000dc;</given-names></name><name><surname>Kula</surname><given-names>M</given-names></name><name><surname>Ta&#x0015f;</surname><given-names>M</given-names></name><name><surname>Tayyar</surname><given-names>M</given-names></name></person-group><article-title>The role of midtrimester amniotic fluid leptin and endothelin-1 levels in prediction of preeclampsia</article-title><source> J Turk Soc Obstet Gynecol</source><year>2012</year><volume>9</volume><fpage>37</fpage><lpage>41</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Tizon</surname><given-names>Larroca S</given-names></name><name><surname>Tayyar</surname><given-names>A</given-names></name><name><surname>Poon</surname><given-names>LC</given-names></name><name><surname>Wright</surname><given-names>D</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name></person-group><article-title>Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks' gestation</article-title><source> Fetal Diagn Ther</source><year>2014</year><volume>36</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">24902880</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asgharnia</surname><given-names>M</given-names></name><name><surname>Faraji</surname><given-names>R</given-names></name><name><surname>Mirhaghjoo</surname><given-names>N</given-names></name><name><surname>Atrkar</surname><given-names>Roshan Z</given-names></name><name><surname>Ashrafkhani</surname><given-names>B</given-names></name><name><surname>Moslehi</surname><given-names>M</given-names></name></person-group><article-title>Survey of predictive value of 4-hour urine collection for diagnosis of proteinuria in preeclampsia</article-title><source> Iran J Reprod Med</source><year>2013</year><volume>11</volume><fpage>647</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">24639802</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibai</surname><given-names>BM</given-names></name></person-group><article-title>Diagnosis and management of gestational hypertension and preeclampsia</article-title><source> Obstet Gynecol</source><year>2003</year><volume>102</volume><fpage>181</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">12850627</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JE</given-names></name></person-group><source>Text book of preventive and social medicine</source><year>2002</year><edition>1st Ed. </edition><publisher-loc>Gillan</publisher-loc><publisher-name> Medical University publication</publisher-name><fpage>237</fpage><lpage>243</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garovic</surname><given-names>VD</given-names></name><name><surname>August</surname><given-names>P</given-names></name></person-group><article-title>Preeclampsia and the future risk of hypertension: the pregnant evidence</article-title><source> Curr Hypertens Rep</source><year>2013</year><volume>15</volume><fpage>114</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">23397213</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saghafi</surname><given-names>N</given-names></name><name><surname>Vatanchi</surname><given-names>AM</given-names></name><name><surname>Tara</surname><given-names>F</given-names></name><name><surname>Pourali</surname><given-names>L</given-names></name><name><surname>Dadgar</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of selected thrombotic factors among pregnant women with preeclampsia and normal pregnant women</article-title><source> Iran J Reprod Med</source><year>2014</year><volume>12</volume><fpage>793</fpage><lpage>798</lpage><pub-id pub-id-type="pmid">25709635</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidrich</surname><given-names>M-B</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>von</surname><given-names>Kaisenberg CS</given-names></name><name><surname>Schippert</surname><given-names>C</given-names></name><name><surname>von</surname><given-names>Versen-H&#x000f6;ynck FM</given-names></name></person-group><article-title>Preeclampsia and long-term risk of cardiovascular disease: what do obstetrician- gynecologists know?</article-title><source> BMC Pregnancy Childbirth</source><year>2013</year><volume>13</volume><fpage>61</fpage><pub-id pub-id-type="pmid">23497157</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>E</given-names></name><name><surname>Harman</surname><given-names>J</given-names></name></person-group><source>Manual of high risk pregnancy and delivery</source><year>2003</year><edition>2nd Ed</edition><publisher-loc>St. Louis</publisher-loc><publisher-name>Mosby</publisher-name><fpage>445</fpage><lpage>462</lpage></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>VM</given-names></name></person-group><article-title>Preeclampsia prevention: a case-control study nested in a cohort</article-title><source> Revista Colombia M&#x000e9;dica</source><year>2016</year><volume>47</volume><fpage>67</fpage><lpage>70</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Devi</surname><given-names>SG</given-names></name><name><surname>Batra</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>C</given-names></name><name><surname>Shukla</surname><given-names>DK</given-names></name></person-group><article-title>Calcium supplementation for the prevention of pre-eclampsia</article-title><source> Int J Gynecol Obstet</source><year>2009</year><volume>104</volume><fpage>32</fpage><lpage>36</lpage></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanagal</surname><given-names>DV</given-names></name><name><surname>Rajesh</surname><given-names>A</given-names></name><name><surname>Rao</surname><given-names>K</given-names></name><name><surname>Devi</surname><given-names>UH</given-names></name><name><surname>Shetty</surname><given-names>H</given-names></name><name><surname>Kumari</surname><given-names>S</given-names></name><etal/></person-group><article-title>Levels of serum calcium and magnesium in pre-eclamptic and normal pregnancy: A study from Coastal India</article-title><source> J Clin Diagn Res</source><year>2014</year><volume>8</volume><fpage>OC01</fpage><lpage>OC0</lpage></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name><name><surname>Kulshreshtha</surname><given-names>S</given-names></name><name><surname>Mohan</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name></person-group><article-title>The role of calcium, magnesium, and zinc in pre-eclampsia</article-title><source> Biol Trace Element Res</source><year>2010</year><volume>133</volume><fpage>162</fpage><lpage>170</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vafaei</surname><given-names>H</given-names></name><name><surname>Dalili</surname><given-names>M</given-names></name><name><surname>Amin</surname><given-names>Hashemi S</given-names></name></person-group><article-title>Serum concentration of calcium, magnesium and zinc in normotensive versus preeclampsia pregnant women: A descriptive study in women of Kerman province of Iran</article-title><source> Int J Reprod BioMed</source><year>2015</year><volume>13</volume><fpage>23</fpage><lpage>26</lpage></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Moon</surname><given-names>JH</given-names></name><name><surname>Jo</surname><given-names>I</given-names></name></person-group><article-title>Serum levels of zinc, calcium, and iron are associated with the risk of preeclampsia in pregnant women</article-title><source> Nutr Res</source><year>2012</year><volume>32</volume><fpage>764</fpage><lpage>769</lpage><pub-id pub-id-type="pmid">23146773</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abedi</surname><given-names>P</given-names></name><name><surname>Mohaghegh</surname><given-names>Z</given-names></name><name><surname>Afshary</surname><given-names>P</given-names></name><name><surname>Latifi</surname><given-names>M</given-names></name></person-group><article-title>The relationship of serum vitamin D with pre&#x02010;eclampsia in the Iranian women</article-title><source> Matern Child Nutr</source><year>2014</year><volume>10</volume><fpage>206</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">23782626</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spinnato</surname><given-names>JA</given-names></name><name><surname>Freire</surname><given-names>S</given-names></name><name><surname>e</surname><given-names>Silva JLP</given-names></name><name><surname>Rudge</surname><given-names>MVC</given-names></name><name><surname>Martins-Costa</surname><given-names>S</given-names></name><name><surname>Koch</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Antioxidant therapy to prevent preeclampsia: a randomized controlled trial</article-title><source> Obstet Gynecol</source><year>2007</year><volume>110</volume><fpage>1311</fpage><lpage>1318</lpage><pub-id pub-id-type="pmid">18055726</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polyzos</surname><given-names>NP</given-names></name><name><surname>Mauri</surname><given-names>D</given-names></name><name><surname>Tsappi</surname><given-names>M</given-names></name><name><surname>Tzioras</surname><given-names>S</given-names></name><name><surname>Kamposioras</surname><given-names>K</given-names></name><name><surname>Cortinovis</surname><given-names>I</given-names></name><etal/></person-group><article-title>Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review</article-title><source> Obstet Gynecol Surv</source><year>2007</year><volume>62</volume><fpage>202</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">17306042</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salles</surname><given-names>AM</given-names></name><name><surname>Galvao</surname><given-names>TF</given-names></name><name><surname>Silva</surname><given-names>MT</given-names></name><name><surname>Motta</surname><given-names>LC</given-names></name><name><surname>Pereira</surname><given-names>MG</given-names></name></person-group><article-title>Antioxidants for preventing preeclampsia: a systematic review</article-title><source> Sci World J</source><year>2012</year><volume>2012</volume><fpage>243476</fpage></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>King</surname><given-names>IB</given-names></name><name><surname>Dashow</surname><given-names>EE</given-names></name><name><surname>Sorensen</surname><given-names>TK</given-names></name><name><surname>Frederick</surname><given-names>IO</given-names></name><name><surname>Thompson</surname><given-names>ML</given-names></name><name><surname>Luthy</surname><given-names>DA</given-names></name></person-group><article-title>Vitamin C and the risk of preeclampsia results from dietary questionnaire and plasma assay</article-title><source> Epidemiology</source><year>2002</year><volume>13</volume><fpage>409</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">12094095</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname><given-names>LC</given-names></name><name><surname>Seed</surname><given-names>PT</given-names></name><name><surname>Brilley</surname><given-names>AL</given-names></name><name><surname>Kelly</surname><given-names>FJ</given-names></name><name><surname>Lee</surname><given-names>R</given-names></name><name><surname>Hunt</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomised trial</article-title><source> Lancet</source><year>1999</year><volume>354</volume><fpage>810</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">10485722</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>RS</given-names></name><name><surname>Mars</surname><given-names>M</given-names></name><name><surname>Chuturgoon</surname><given-names>AA</given-names></name><name><surname>Dutlon</surname><given-names>MF</given-names></name></person-group><article-title>The response of dietary antioxidants vitamin E and vitamin C to oxidative stress in preeclampsia</article-title><source> J Obstet Gynecol</source><year>1998</year><volume>18</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">15511992</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabirieskoei</surname><given-names>A</given-names></name><name><surname>Mazlumzade</surname><given-names>S</given-names></name><name><surname>Amir</surname><given-names>moghademi H</given-names></name><name><surname>Akbar</surname><given-names>shahiO</given-names></name><name><surname>Eskanderi</surname><given-names>M</given-names></name></person-group><article-title>Compare Bararleptin levels in women with preeclampsia and women with normal blood pressure Bardarba referred to Vali-e Zanjan Center</article-title><source> J Zanjan Univ Med Sci</source><year>2012</year><volume>77</volume><fpage>70</fpage><lpage>77</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>TE</given-names></name><name><surname>Ray</surname><given-names>JG</given-names></name><name><surname>Chan</surname><given-names>WS</given-names></name></person-group><article-title>Maternal body mass index and the risk of preeclampsia: a systematic overview</article-title><source> Epidemiology</source><year>2003</year><volume>14</volume><fpage>368</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">12859040</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asemi</surname><given-names>Z</given-names></name><name><surname>Razavi</surname><given-names>BS</given-names></name><name><surname>Ebrahimi</surname><given-names>Z</given-names></name><name><surname>Baniahmadi</surname><given-names>Z</given-names></name><name><surname>Salehi</surname><given-names>S</given-names></name><name><surname>Nazemi</surname><given-names>F</given-names></name><etal/></person-group><article-title>A randomized controlled clinical trial evaluating the effect of multi mineral-vitamin D supplementation on pregnancy outcomes in pregnant women at risk for pre-eclampsia</article-title><source> FEYZ</source><year>2013</year><volume>16</volume><fpage>765</fpage><lpage>766</lpage></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>CJ</given-names></name><name><surname>Wagner</surname><given-names>CL</given-names></name><name><surname>Hollis</surname><given-names>BW</given-names></name><name><surname>Baatz</surname><given-names>JE</given-names></name></person-group><article-title>Maternal vitamin D and fetal growth in early-onset severe preeclampsia</article-title><source> Am J Obstet Gynecol</source><year>2011</year><volume>204</volume><fpage>556</fpage><pub-id pub-id-type="pmid">21507371</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghomian</surname><given-names>N</given-names></name><name><surname>Lotfalizade</surname><given-names>M</given-names></name><name><surname>Mohedian</surname><given-names>A</given-names></name></person-group><article-title>A comparative study of serum levels of vitamin D in women with severe preeclampsia and healthy pregnant women</article-title><source> J Obstet Gynecol Infertil</source><year>2015</year><volume>18</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumbold</surname><given-names>A</given-names></name><name><surname>Duely</surname><given-names>L</given-names></name><name><surname>Crowther</surname><given-names>CA</given-names></name><name><surname>Haslam</surname><given-names>RR</given-names></name></person-group><article-title>Antioxidants for preventing preeclampsia</article-title><source> Cochrane Database Syst Rev</source><year>2008</year><volume>23</volume><fpage>CD004227</fpage></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumbold</surname><given-names>AR</given-names></name><name><surname>Crowther</surname><given-names>CA</given-names></name><name><surname>Haslam</surname><given-names>RR</given-names></name><name><surname>Dekker</surname><given-names>GA</given-names></name><name><surname>Robinson</surname><given-names>JS</given-names></name></person-group><article-title>Vitamin C and E and the risks of preeclampsia and perinatal complications</article-title><source> N Engl J Med</source><year>2006</year><volume>354</volume><fpage>1796</fpage><lpage>1806</lpage><pub-id pub-id-type="pmid">16641396</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahmanian</surname><given-names>M</given-names></name><name><surname>Aghayan</surname><given-names>SH</given-names></name><name><surname>GHorbani</surname><given-names>R</given-names></name></person-group><article-title>The effect of combined administration of vitamin E and C in the prevention of soil Lampsy blades and some pregnancy outcomes in nulliparous pregnant women</article-title><source> J Obstet Gynecol Infertil</source><year>2011</year><volume>14</volume><fpage>22</fpage><lpage>27</lpage></element-citation></ref></ref-list></back></article>